Inhaled nitric oxide in primary pulmonary hypertension
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
Survival in Patients with Primary Pulmonary Hypertension
1991 • 3,369 citations
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 • 2,590 citations
Primary Pulmonary Hypertension
1987 • 2,027 citations
Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
1993 • 1,811 citations
Primary Pulmonary Hypertension
1997 • 1,748 citations
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 • 1,541 citations
Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension
1996 • 1,131 citations
Primary pulmonary hypertension: natural history and the importance of thrombosis.
1984 • 1,077 citations
Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
1991 • 1,062 citations
Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn
1997 • 787 citations
The cardiac effects of adenosine
1989 • 779 citations
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
1997 • 582 citations
Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin
1994 • 558 citations
Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.
1993 • 371 citations
High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.
1987 • 365 citations
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.
1995 • 303 citations
Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease
1996 • 269 citations
Single Lung Transplantation for Pulmonary Hypertension
1995 • 208 citations
The Acute Administration of Vasodilators in Primary Pulmonary Hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension
1989 • 188 citations
Pharmacologically induced Pulmonary Vasodilatation in Children and Young Adults with Primary Pulmonary Hypertension
1986 • 156 citations
Adenosine as a vasodilator in primary pulmonary hypertension.
1991 • 119 citations
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension
1996 • 104 citations
Comparison of the effects of adenosine and nifedipine in pulmonary hypertension
1992 • 104 citations
PGI<sub>2</sub> Aerosol versus Nitric Oxide for Selective Pulmonary Vasodilation in Hypoxic Pulmonary Vasoconstriction
1993 • 102 citations
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
1997 • 88 citations
Inhaled Nitric Oxide Used as a Bridge to Heart-Lung Transplantation in a Patient with End-stage Pulmonary Hypertension
1995 • 79 citations
Caution with use of inhaled nitric oxide
1996 • 62 citations
The interaction between nitrogen oxides and hemoglobin and endothelium-derived relaxing factor
1989 • 60 citations
Ion Flux in Pulmonary Vascular Control
1993 • 40 citations
Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension
1993 • 40 citations
Clinical Applications of Inhaled Nitric Oxide in Children with Pulmonary Hypertension
1995 • 27 citations
Correlation of Acute Prostacyclin Response in Primary (Unexplained) Pulmonary Hypertension with Efficacy of Treatment with Calcium Channel Blockers and Survival
1993 • 24 citations